Header Logo

Shiyoung Roh

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glaucoma, Open-Angle
7
2025
50
1.010
 Why?
Telemedicine
7
2025
363
0.970
 Why?
Glaucoma
4
2023
64
0.690
 Why?
Intraocular Pressure
7
2023
73
0.560
 Why?
Diabetic Retinopathy
3
2024
60
0.550
 Why?
Patient Portals
2
2025
53
0.420
 Why?
Macular Degeneration
2
2024
195
0.310
 Why?
Product Packaging
1
2008
4
0.280
 Why?
Hyphema
1
2008
3
0.280
 Why?
Eye Injuries
1
2008
13
0.280
 Why?
Diabetes Mellitus
2
2023
555
0.260
 Why?
Wounds, Nonpenetrating
1
2008
116
0.250
 Why?
Geographic Atrophy
1
2024
20
0.200
 Why?
Visual Acuity
3
2024
133
0.200
 Why?
Wet Macular Degeneration
1
2023
24
0.200
 Why?
Ophthalmology
1
2022
27
0.180
 Why?
Smartphone
1
2021
73
0.160
 Why?
Dark Adaptation
1
2019
8
0.150
 Why?
Follow-Up Studies
4
2024
2482
0.110
 Why?
Humans
16
2025
64935
0.110
 Why?
Pandemics
3
2023
672
0.100
 Why?
Intravitreal Injections
2
2024
54
0.100
 Why?
Optic Nerve
2
2023
25
0.090
 Why?
Patient Compliance
2
2024
364
0.090
 Why?
Anterior Chamber
1
2008
4
0.070
 Why?
Antihypertensive Agents
2
2007
178
0.070
 Why?
Phacoemulsification
1
2007
8
0.070
 Why?
Trabeculectomy
1
2007
9
0.070
 Why?
Cataract
1
2007
54
0.070
 Why?
Prostaglandins F, Synthetic
1
2006
1
0.060
 Why?
Amides
1
2006
60
0.060
 Why?
Aged
5
2025
14917
0.060
 Why?
Female
6
2025
33917
0.050
 Why?
Cross-Sectional Studies
2
2021
2701
0.050
 Why?
Lipids
1
2006
327
0.050
 Why?
Middle Aged
4
2025
18203
0.050
 Why?
Telephone
1
2023
122
0.050
 Why?
Appointments and Schedules
1
2023
60
0.050
 Why?
Ranibizumab
1
2021
21
0.040
 Why?
Nerve Fibers
1
2021
31
0.040
 Why?
Retinal Ganglion Cells
1
2021
30
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2021
36
0.040
 Why?
Bevacizumab
1
2021
60
0.040
 Why?
Diagnostic Techniques, Ophthalmological
1
2021
11
0.040
 Why?
Male
5
2025
30942
0.040
 Why?
Angiogenesis Inhibitors
1
2021
82
0.040
 Why?
Photography
1
2021
42
0.040
 Why?
Retina
1
2021
132
0.040
 Why?
Recombinant Fusion Proteins
1
2021
500
0.040
 Why?
Visual Fields
1
2019
51
0.040
 Why?
Disease Progression
1
2023
1214
0.040
 Why?
Retrospective Studies
2
2021
6840
0.040
 Why?
Tomography, Optical Coherence
1
2021
235
0.040
 Why?
Patient Satisfaction
1
2021
434
0.030
 Why?
Referral and Consultation
1
2021
439
0.030
 Why?
Adolescent
1
2008
6292
0.030
 Why?
Prospective Studies
2
2019
3305
0.030
 Why?
Pilot Projects
1
2019
1013
0.030
 Why?
Reproducibility of Results
1
2019
1691
0.030
 Why?
Aged, 80 and over
2
2019
5600
0.030
 Why?
Risk Factors
1
2022
5406
0.020
 Why?
Surveys and Questionnaires
1
2019
2759
0.020
 Why?
Tonometry, Ocular
1
2007
20
0.020
 Why?
Lens Implantation, Intraocular
1
2007
8
0.020
 Why?
Mitomycin
1
2007
27
0.020
 Why?
Bimatoprost
1
2006
1
0.020
 Why?
Cloprostenol
1
2006
1
0.020
 Why?
Ophthalmic Solutions
1
2006
8
0.020
 Why?
Double-Blind Method
1
2006
739
0.010
 Why?
Circadian Rhythm
1
2006
361
0.010
 Why?
Adult
1
2019
17307
0.010
 Why?
Roh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_